|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hirokawa N, Noda Y, Tanaka Y and Niwa S:
Kinesin superfamily motor proteins and intracellular transport. Nat
Rev Mol Cell Biol. 10:682–696. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu W and Gelfand VI: Moonlighting motors:
kinesin, dynein, and cell polarity. Trends Cell Biol. 27:505–514.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rath O and Kozielski F: Kinesins and
cancer. Nat Rev Cancer. 12:527–539. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weinstein JN, Collisson EA, Mills GB, Shaw
KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C and Stuart JM;
Cancer Genome Atlas Research Network, : The Cancer Genome Atlas
Pan-Cancer analysis project. Nat Genet. 45:1113–1120. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The Cancer Genome Atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn) 19A. A68–A77. 2015.
|
|
8
|
Xia P, Chu S, Liu G, Chen G, Yi T, Feng S
and Zhou H: High expression of KIF3A is a potential new parameter
for the diagnosis and prognosis of breast cancer. Biomed Rep.
8:343–349. 2018.PubMed/NCBI
|
|
9
|
Xue D, Cheng P, Han M, Liu X, Xue L, Ye C,
Wang K and Huang J: An integrated bioinformatical analysis to
evaluate the role of KIF4A as a prognostic biomarker for breast
cancer. OncoTargets Ther. 11:4755–4768. 2018. View Article : Google Scholar
|
|
10
|
Gao H, Chen X, Cai Q, Shang Z and Niu Y:
Increased KIF4A expression is a potential prognostic factor in
prostate cancer. Oncol Lett. 15:7941–7947. 2018.PubMed/NCBI
|
|
11
|
Song X, Zhang T, Wang X, Liao X, Han C,
Yang C, Su K, Cao W, Gong Y, Chen Z, et al: Distinct diagnostic and
prognostic values of kinesin family member genes expression in
patients with breast cancer. Med Sci Monit. 24:9442–9464. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xie T, Li X, Ye F, Lu C, Huang H, Wang F,
Cao X and Zhong C: High KIF2A expression promotes proliferation,
migration and predicts poor prognosis in lung adenocarcinoma.
Biochem Biophys Res Commun. 497:65–72. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hung PF, Hong TM, Hsu YC, Chen HY, Chang
YL, Wu CT, Chang GC, Jou YS, Pan SH and Yang PC: The motor protein
KIF14 inhibits tumor growth and cancer metastasis in lung
adenocarcinoma. PLoS One. 8:e616642013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao X, Zhou LL, Li X, Ni J, Chen P, Ma R,
Wu J and Feng J: Overexpression of KIF20A confers malignant
phenotype of lung adenocarcinoma by promoting cell proliferation
and inhibiting apoptosis. Cancer Med. 7:4678–4689. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular profiling of lung adenocarcinoma. Nature.
511:543–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Anders S and Huber W: Differential
expression analysis for sequence count data. Genome Biol.
11:R1062010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liao X, Zhu G, Huang R, Yang C, Wang X,
Huang K, Yu T, Han C, Su H and Peng T: Identification of potential
prognostic microRNA biomarkers for predicting survival in patients
with hepatocellular carcinoma. Cancer Manag Res. 10:787–803. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liao X, Liu X, Yang C, Wang X, Yu T, Han
C, Huang K, Zhu G, Su H, Qin W, et al: Distinct diagnostic and
prognostic values of minichromosome maintenance gene expression in
patients with hepatocellular carcinoma. J Cancer. 9:2357–2373.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liao X, Wang X, Huang K, Yang C, Yu T, Han
C, Zhu G, Su H, Huang R and Peng T: Genome-scale analysis to
identify prognostic microRNA biomarkers in patients with early
stage pancreatic ductal adenocarcinoma after
pancreaticoduodenectomy. Cancer Manag Res. 10:2537–2551. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao X, Yang C, Huang R, Han C, Yu T,
Huang K, Liu X, Yu L, Zhu G, Su H, et al: Identification of
potential prognostic long non-coding RNA biomarkers for predicting
survival in patients with hepatocellular carcinoma. Cell Physiol
Biochem. 48:1854–1869. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang R, Liao X and Li Q: Identification
and validation of potential prognostic gene biomarkers for
predicting survival in patients with acute myeloid leukemia.
OncoTargets Ther. 10:5243–5254. 2017. View Article : Google Scholar
|
|
22
|
Liao X, Huang K, Huang R, Liu X, Han C, Yu
L, Yu T, Yang C, Wang X and Peng T: Genome-scale analysis to
identify prognostic markers in patients with early-stage pancreatic
ductal adenocarcinoma after pancreaticoduodenectomy. OncoTargets
Ther. 10:4493–4506. 2017. View Article : Google Scholar
|
|
23
|
Heagerty PJ and Zheng Y: Survival model
predictive accuracy and ROC curves. Biometrics. 61:92–105. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES, et al: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mootha VK, Lindgren CM, Eriksson KF,
Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E,
Ridderstråle M, Laurila E, et al: PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat Genet. 34:267–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liberzon A, Birger C, Thorvaldsdóttir H,
Ghandi M, Mesirov JP and Tamayo P: The Molecular Signatures
Database (MSigDB) hallmark gene set collection. Cell Syst.
1:417–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sheng N, Xu YZ, Xi QH, Jiang HY, Wang CY,
Zhang Y and Ye Q: Overexpression of KIF2A is suppressed by miR-206
and associated with poor prognosis in ovarian cancer. Cell Physiol
Biochem. 50:810–822. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Yuan Y, Liang P, Zhang Z, Guo X,
Xia L, Zhao Y, Shu XS, Sun S, Ying Y, et al: Overexpression of a
novel candidate oncogene KIF14 correlates with tumor progression
and poor prognosis in prostate cancer. Oncotarget. 8:45459–45469.
2017.PubMed/NCBI
|
|
29
|
Xu H, Choe C, Shin SH, Park SW, Kim HS,
Jung SH, Yim SH, Kim TM and Chung YJ: Silencing of KIF14 interferes
with cell cycle progression and cytokinesis by blocking the
p27(Kip1) ubiquitination pathway in hepatocellular carcinoma. Exp
Mol Med. 46:e972014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, You X, Liu H, Xu M, Dang Q, Yang
L, Huang J and Shi W: High KIF2A expression predicts unfavorable
prognosis in diffuse large B cell lymphoma. Ann Hematol.
96:1485–1491. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang Y, Wang H, Lian Y, Wu X, Zhou L,
Wang J, Deng M and Huang Y: Upregulation of kinesin family member
4A enhanced cell proliferation via activation of Akt signaling and
predicted a poor prognosis in hepatocellular carcinoma. Cell Death
Dis. 9:1412018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hou G, Dong C, Dong Z, Liu G, Xu H, Chen
L, Liu L, Wang H and Zhou W: Upregulate KIF4A enhances
proliferation, invasion of hepatocellular carcinoma and indicates
poor prognosis across human cancer types. Sci Rep. 7:41482017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Daigo K, Takano A, Thang PM, Yoshitake Y,
Shinohara M, Tohnai I, Murakami Y, Maegawa J and Daigo Y:
Characterization of KIF11 as a novel prognostic biomarker and
therapeutic target for oral cancer. Int J Oncol. 52:155–165.
2018.PubMed/NCBI
|
|
34
|
Pei YY, Li GC, Ran J and Wei FX: Kinesin
family member 11 contributes to the progression and prognosis of
human breast cancer. Oncol Lett. 14:6618–6626. 2017.PubMed/NCBI
|
|
35
|
Yang X, Zhang L and Xie L: Upregulation of
KIF26B, cell migration and proliferation of human ovarian cancer
cell lines in vitro, and patient outcomes from human bioinformatic
analysis. Med Sci Monit. 24:3863–3872. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu X, Li Y, Zhang X, Liu XY, Peng A, Chen
Y, Meng L, Chen H, Zhang Y, Miao X, et al: Inhibition of kinesin
family member 20B sensitizes hepatocellular carcinoma cell to
microtubule-targeting agents by blocking cytokinesis. Cancer Sci.
109:3450–3460. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qiu HL, Deng SZ, Li C, Tian ZN, Song XQ,
Yao GD and Geng JS: High expression of KIF14 is associated with
poor prognosis in patients with epithelial ovarian cancer. Eur Rev
Med Pharmacol Sci. 21:239–245. 2017.PubMed/NCBI
|
|
38
|
Thériault BL, Pajovic S, Bernardini MQ,
Shaw PA and Gallie BL: Kinesin family member 14: An independent
prognostic marker and potential therapeutic target for ovarian
cancer. Int J Cancer. 130:1844–1854. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou Z, Cheng Y, Jiang Y, Liu S, Zhang M,
Liu J and Zhao Q: Ten hub genes associated with progression and
prognosis of pancreatic carcinoma identified by co-expression
analysis. Int J Biol Sci. 14:124–136. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang W, Shi Y, Li J, Cui W and Yang B:
Up-regulation of KIF14 is a predictor of poor survival and a novel
prognostic biomarker of chemoresistance to paclitaxel treatment in
cervical cancer. Biosci Rep. 36:e003152016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Corson TW and Gallie BL: KIF14 mRNA
expression is a predictor of grade and outcome in breast cancer.
Int J Cancer. 119:1088–1094. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang Q, Wang L, Li D, Deng J, Zhao Z, He
S, Zhang Y and Tu Y: Kinesin family member 14 is a candidate
prognostic marker for outcome of glioma patients. Cancer Epidemiol.
37:79–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang Z, Li C, Yan C, Li J, Yan M, Liu B,
Zhu Z, Wu Y and Gu Q: KIF14 promotes tumor progression and
metastasis and is an independent predictor of poor prognosis in
human gastric cancer. Biochim Biophys Acta Mol Basis Dis 1865.
181–192. 2019. View Article : Google Scholar
|
|
44
|
Li KK, Qi Y, Xia T, Chan AK, Zhang ZY,
Aibaidula A, Zhang R, Zhou L, Yao Y and Ng HK: The kinesin KIF14 is
overexpressed in medulloblastoma and downregulation of KIF14
suppressed tumor proliferation and induced apoptosis. Lab Invest.
97:946–961. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Corson TW, Zhu CQ, Lau SK, Shepherd FA,
Tsao MS and Gallie BL: KIF14 messenger RNA expression is
independently prognostic for outcome in lung cancer. Clin Cancer
Res. 13:3229–3234. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang T, Zhang XB and Zheng ZM: Suppression
of KIF14 expression inhibits hepatocellular carcinoma progression
and predicts favorable outcome. Cancer Sci. 104:552–557. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wu Y, Wang A, Zhu B, Huang J, Lu E, Xu H,
Xia W, Dong G, Jiang F and Xu L: KIF18B promotes tumor progression
through activating the Wnt/β-catenin pathway in cervical cancer.
OncoTargets Ther. 11:1707–1720. 2018. View Article : Google Scholar
|
|
48
|
Itzel T, Scholz P, Maass T, Krupp M,
Marquardt JU, Strand S, Becker D, Staib F, Binder H, Roessler S, et
al: Translating bioinformatics in oncology: Guilt-by-profiling
analysis and identification of KIF18B and CDCA3 as novel driver
genes in carcinogenesis. Bioinformatics. 31:216–224. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu SL, Lin HX, Qiu F, Zhang WJ, Niu CH,
Wen W, Sun XQ, Ye LP, Wu XQ, Lin CY, et al: Overexpression of
kinesin family member 20A correlates with disease progression and
poor prognosis in human nasopharyngeal cancer: A retrospective
analysis of 105 patients. PLoS One. 12:e01692802017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yang G, Chen Q, Xiao J, Zhang H, Wang Z
and Lin X: Identification of genes and analysis of prognostic
values in nonsmoking females with non-small cell lung carcinoma by
bioinformatics analyses. Cancer Manag Res. 10:4287–4295. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ni M, Liu X, Wu J, Zhang D, Tian J, Wang
T, Liu S, Meng Z, Wang K, Duan X, et al: Identification of
candidate biomarkers correlated with the pathogenesis and prognosis
of non-small cell lung cancer via integrated bioinformatics
analysis. Front Genet. 9:4692018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shi C, Huang D, Lu N, Chen D, Zhang M, Yan
Y, Deng L, Lu Q, Lu H and Luo S: Aberrantly activated Gli2-KIF20A
axis is crucial for growth of hepatocellular carcinoma and predicts
poor prognosis. Oncotarget. 7:26206–26219. 2016.PubMed/NCBI
|
|
53
|
Zhang W, He W, Shi Y, Gu H, Li M, Liu Z,
Feng Y, Zheng N, Xie C and Zhang Y: High expression of KIF20A is
associated with poor overall survival and tumor progression in
early-stage cervical squamous cell carcinoma. PLoS One.
11:e01674492016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Saito K, Ohta S, Kawakami Y, Yoshida K and
Toda M: Functional analysis of KIF20A, a potential
immunotherapeutic target for glioma. J Neurooncol. 132:63–74. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li H, Zhang W, Sun X, Chen J, Li Y, Niu C,
Xu B and Zhang Y: Overexpression of kinesin family member 20A is
associated with unfavorable clinical outcome and tumor progression
in epithelial ovarian cancer. Cancer Manag Res. 10:3433–3450. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yuan L, Chen L, Qian K, Qian G, Wu CL,
Wang X and Xiao Y: Co-expression network analysis identified six
hub genes in association with progression and prognosis in human
clear cell renal cell carcinoma (ccRCC). Genom Data. 14:132–140.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yamashita J, Fukushima S, Jinnin M, Honda
N, Makino K, Sakai K, Masuguchi S, Inoue Y and Ihn H: Kinesin
family member 20A is a novel melanoma-associated antigen. Acta Derm
Venereol. 92:593–597. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kawai Y, Shibata K, Sakata J, Suzuki S,
Utsumi F, Niimi K, Sekiya R, Senga T, Kikkawa F and Kajiyama H:
KIF20A expression as a prognostic indicator and its possible
involvement in the proliferation of ovarian clear-cell carcinoma
cells. Oncol Rep. 40:195–205. 2018.PubMed/NCBI
|
|
59
|
Carleton M, Mao M, Biery M, Warrener P,
Kim S, Buser C, Marshall CG, Fernandes C, Annis J and Linsley PS:
RNA interference-mediated silencing of mitotic kinesin KIF14
disrupts cell cycle progression and induces cytokinesis failure.
Mol Cell Biol. 26:3853–3863. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Singel SM, Cornelius C, Zaganjor E, Batten
K, Sarode VR, Buckley DL, Peng Y, John GB, Li HC, Sadeghi N, et al:
KIF14 promotes AKT phosphorylation and contributes to
chemoresistance in triple-negative breast cancer. Neoplasia.
16:247–256, 256 e242. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang ZZ, Yang J, Jiang BH, Di JB, Gao P,
Peng L and Su XQ: KIF14 promotes cell proliferation via activation
of Akt and is directly targeted by miR-200c in colorectal cancer.
Int J Oncol. 53:1939–1952. 2018.PubMed/NCBI
|
|
62
|
Xiu G, Sui X, Wang Y and Zhang Z: FOXM1
regulates radiosensitivity of lung cancer cell partly by
upregulating KIF20A. Eur J Pharmacol. 833:79–85. 2018. View Article : Google Scholar : PubMed/NCBI
|
